Aeglea BioTherapeutics
spy is a potentially best in class anti a with near term risking studies anticipated | Aeglea BioTherapeutics
Deck date
September 2023
Slide
26 of 56
Similar slides by Aeglea BioTherapeutics
Investor Presentation
September 2023
Investor Presentation
July 2023
Investor Presentation
July 2023
Mergers and Acquisitions
June 2023
Related slides by other companies
Results
October 2023
Investor Presentation
June 2022
IPO
April 2022
Investor Conference
January 2024
Other recent decks by Aeglea BioTherapeutics
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
July 2023
Mergers and Acquisitions
June 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io